Mark Benedyk
Direttore/Membro del Consiglio presso Accel-Rx
Profilo
Mark Benedyk is the founder of Telephus Medical LLC, which was founded in 2012.
He held the titles of President & Chief Executive Officer from 2012 to 2018.
Currently, he is a Director at Alafair Biosciences, Inc., The Centre for Drug Research & Development, Accel-Rx, Pulmotect, Inc., and Managing Partner at Rila Partners LLC.
He previously worked as a Director at Amarantus Bioscience Holdings, Inc. in 2013.
Dr. Benedyk received his undergraduate degree from the University of Michigan and his doctorate from The Rockefeller University.
Posizioni attive di Mark Benedyk
Società | Posizione | Inizio |
---|---|---|
Rila Partners LLC | Corporate Officer/Principal | - |
The Centre for Drug Research & Development
The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | - |
Accel-Rx
Accel-Rx Financial ConglomeratesFinance Accel-Rx provides seed and start-up investment services to the new health sciences companies. It engages in leveraging investment support to the research and commercialization centers such as the existing health-related Centers of Excellence for Commercialization and Research (CECRs). The company was founded by Natalie Dakers in 2014 and is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | - |
Pulmotect, Inc.
Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX. | Direttore/Membro del Consiglio | - |
Alafair Biosciences, Inc.
Alafair Biosciences, Inc. Medical SpecialtiesHealth Technology Alafair Biosciences, Inc. operates as a medical device company. It develops novel suite of products based on a non-cell adhesive hydrogel technology that protects and manages advanced wound healing. The firm addresses problems of wound healing and scar prevention with natural, animal-free biopolymer based products that are biocompatible, bioresorbable and hydrate injured tissues throughout healing. The company was founded by Daniel L. Peterson, John D. Joyoprayitno and Sarah Mayes in 2011 and is headquartered in Austin, TX. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Mark Benedyk
Società | Posizione | Fine |
---|---|---|
Telephus Medical LLC
Telephus Medical LLC Miscellaneous Commercial ServicesCommercial Services Telephus Medical LLC is a biotechnology company that develops immunotherapy products. The private company is based in Rochester, NY and was founded in 2012 by Mark Benedyk. | Amministratore Delegato | 01/10/2018 |
AMARANTUS BIOSCIENCE HOLDINGS, INC. | Direttore/Membro del Consiglio | - |
Formazione di Mark Benedyk
University of Michigan | Undergraduate Degree |
The Rockefeller University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
AMARANTUS BIOSCIENCE HOLDINGS, INC. | Health Technology |
Aziende private | 6 |
---|---|
Alafair Biosciences, Inc.
Alafair Biosciences, Inc. Medical SpecialtiesHealth Technology Alafair Biosciences, Inc. operates as a medical device company. It develops novel suite of products based on a non-cell adhesive hydrogel technology that protects and manages advanced wound healing. The firm addresses problems of wound healing and scar prevention with natural, animal-free biopolymer based products that are biocompatible, bioresorbable and hydrate injured tissues throughout healing. The company was founded by Daniel L. Peterson, John D. Joyoprayitno and Sarah Mayes in 2011 and is headquartered in Austin, TX. | Health Technology |
The Centre for Drug Research & Development
The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Commercial Services |
Accel-Rx
Accel-Rx Financial ConglomeratesFinance Accel-Rx provides seed and start-up investment services to the new health sciences companies. It engages in leveraging investment support to the research and commercialization centers such as the existing health-related Centers of Excellence for Commercialization and Research (CECRs). The company was founded by Natalie Dakers in 2014 and is headquartered in Vancouver, Canada. | Finance |
Pulmotect, Inc.
Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX. | Health Technology |
Telephus Medical LLC
Telephus Medical LLC Miscellaneous Commercial ServicesCommercial Services Telephus Medical LLC is a biotechnology company that develops immunotherapy products. The private company is based in Rochester, NY and was founded in 2012 by Mark Benedyk. | Commercial Services |
Rila Partners LLC |
- Borsa valori
- Insiders
- Mark Benedyk